Multiple sclerosis after infectious mononucleosis: Record linkage study

Journal of Epidemiology and Community Health

Volumn 58, Issue 12, 2004, Pages 1032-1035

  Goldacre, Michael J ^a,b   Wotton, Clare J ^b   Seagroatt, Valerie ^b   Yeates, David ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH RISK; RISK FACTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; EPSTEIN BARR VIRUS; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; ONSET AGE; PATHOGENESIS; RISK FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ENGLAND; HOSPITALIZATION; HUMANS; INFECTIOUS MONONUCLEOSIS; MEDICAL RECORD LINKAGE; MULTIPLE SCLEROSIS; RISK FACTORS;

EASTERN HEMISPHERE; ENGLAND; EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE; WORLD;

EID: 9444219643     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2003.018366     Document Type: Article

References (18)

1. Dean G. Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa. BMJ 1967;ii:724-30.
2. Warner HB, Camp RI. Multiple sclerosis and Epstein-Barr virus, Lancet 1981;ii:1290.
3. Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000;11:220-4.
4. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis (a prospective study). JAMA 2001;286:3083-8.
5. Levin LI, Munger KL, Rubertone MV, et al. Multiple sclerosis and Epstein-Barr virus. JAMA 2003;289:1533-6.
6. Wandinger K, Jabs W, Siekhaus A, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000;55:178-84.
7. Marrie RA, Wolfson C, Sturkenboom MC, et al. Multiple sclerosis and antecedent infections: a case-control study. Neurology 2000;54:2307-10.
8. Lindberg C, Andersen O, Vahlne A, et al. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991;10:62-5.
9. Goldacre M, Kurina L, Yeates D, et al. Use of large medical databases to study associations between diseases. Q J Med 2000;93:669-75.
10. Breslow NE, Dav NE. Statistical methods in cancer research, Volume 11. The design and analysis of cohort studies. IARC scientific publication no 82. Lyon: International Agency for Research in Cancer, 1987:103-5.
11. Jersild C, Grunnet N. Demyelinating disease. In: King RA, Rotter JI, Motulsky AG, eds. The genetic basis of common diseases. Oxford: Oxford University Press, 1992:753-74.
12. Ben-Shlomo Y, Davey Smith G, Marmot MG. Dietary fat in the epidemiology of multiple sclerosis: has the situation been adequately assessed? Neuroepidemiology 1992;11:214-25.
13. van der Mei IAF, Ponsonby A-L, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316-19.
14. Goldacre MJ, Seagroatt V, Yeates D, et al. Skin cancer in people with multiple sclerosis: a record linkage study. J Epidemiol Community Health 2004;58:142-4.
15. Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000;59:531-5.
16. Yuen P. Office of Health Economics compendium of health statistics. London: Office of Health Economics 2002, section 2, 1-7.
17. Kendrick S, Clarke J. The Scottish record linkage system. Health Bull 1993;51:72-9.
18. Holman CD, Bass AJ, Rouse IL. et al. Population-based linkage of health records in Western Australia: development of a health services research linked database, Australian and New Zealand Journal of Public Health, 1999;23:453-9.